| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $0 | 0 | – |
Sells | $0 | 0 | – |
Coherus Oncology, Inc. is a biopharmaceutical company primarily focused on the research, development, and commercialization of cancer immunotherapies across the United States. The company's commercialized products include several biosimilar therapies. These comprise UDENYCA, a long-acting granulocyte-colony stimulating factor biosimilar to Neulasta; YUSIMRY, an equivalent to Humira, prescribed for inflammatory conditions like rheumatoid arthritis, psoriasis, and Crohn's disease, which are characterized by heightened tumor necrosis factor (TNF) …
Over the last 12 months, insiders at Coherus Oncology, Inc. have bought $0 and sold $0 worth of Coherus Oncology, Inc. stock.
On average, over the past 5 years, insiders at Coherus Oncology, Inc. have bought $0 and sold $261,825 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 3,700 shares for transaction amount of $49,668 was made by Stilwell McDavid (Chief Financial Officer) on 2021‑06‑09.
| 2025-05-23 | Sale | Wahlstrom Mats | director | 99,988 0.0843% | $0.74 | $73,881 | +99.05% | |
| 2023-11-22 | Sale | Lanfear Dennis M | President & CEO | 223,100 0.2098% | $2.02 | $449,770 | -6.44% | |
| 2021-10-15 | Sale | Stilwell McDavid | Chief Financial Officer | 3,507 0.0045% | $16.80 | $58,919 | -30.65% | |
| 2021-09-29 | Sale | HEALY JAMES | director | 286,076 0.3546% | $16.12 | $4.61M | -26.09% | |
| 2021-09-28 | Sale | HEALY JAMES | director | 48,329 0.0622% | $17.17 | $829,809 | -27.59% | |
| 2021-09-27 | Sale | HEALY JAMES | director | 100,150 0.1287% | $18.06 | $1.81M | -30.86% | |
| 2021-06-09 | Stilwell McDavid | Chief Financial Officer | 3,700 0.0049% | $13.42 | $49,668 | +0.96% | ||
| 2021-06-08 | Sale | Lanfear Dennis M | President & CEO | 31,054 0.0411% | $13.56 | $421,229 | +0.59% | |
| 2021-03-09 | Sale | Vexler Vladimir | Chief Scientific Officer | 114,240 0.1583% | $16.25 | $1.86M | -9.44% | |
| 2021-03-05 | Sale | Anicetti Vincent R | Chief Operating Officer | 26,649 0.0357% | $15.46 | $412,065 | -7.55% | |
| 2021-02-17 | Sale | Anicetti Vincent R | Chief Operating Officer | 2,488 0.0034% | $17.45 | $43,418 | -13.71% | |
| 2021-02-01 | Sale | Viret Jean-Frederic | Chief Financial Officer | 7,402 0.0124% | $21.55 | $159,513 | -13.35% | |
| 2021-01-25 | Sale | Viret Jean-Frederic | Chief Financial Officer | 46,144 0.0647% | $19.95 | $920,736 | -21.18% | |
| 2021-01-19 | Sale | Anicetti Vincent R | Chief Operating Officer | 2,500 0.0034% | $17.94 | $44,852 | -13.26% | |
| 2020-12-17 | Sale | Anicetti Vincent R | Chief Operating Officer | 2,500 0.0034% | $17.51 | $43,780 | -10.94% | |
| 2020-12-10 | Sale | Vexler Vladimir | Chief Scientific Officer | 17,626 0.0246% | $18.05 | $318,066 | -11.68% | |
| 2020-12-09 | Sale | Vexler Vladimir | Chief Scientific Officer | 49,512 0.0685% | $18.24 | $903,084 | -13.28% | |
| 2020-12-07 | Sale | Anicetti Vincent R | Chief Operating Officer | 8,791 0.0122% | $18.42 | $161,896 | -13.80% | |
| 2020-12-04 | Sale | Anicetti Vincent R | Chief Operating Officer | 49,000 0.0675% | $18.85 | $923,694 | -16.42% | |
| 2020-12-03 | Sale | Anicetti Vincent R | Chief Operating Officer | 49,756 0.0692% | $18.67 | $929,079 | -14.87% |
| LILLY ELI & CO | 3042019 1.9689% | $2.45M | 1 | 0 | +82.59% | |
| Stilwell McDavid | Chief Financial Officer | 31611 0.0205% | $25,465.82 | 1 | 1 | +0.96% |
| HEALY JAMES | director | 0 0% | $0 | 1 | 8 | +82.59% |
$16,280,851 | 76 | 1.48% | $118.27M | |
$4,898,715 | 46 | 40.75% | $114.69M | |
$130,095 | 43 | 45.19% | $111.24M | |
$6,788,859 | 35 | 26.72% | $151.54M | |
$47,438,336 | 33 | -21.38% | $122.37M |
| Increased Positions | 64 | +53.33% | 5M | +9.6% |
| Decreased Positions | 44 | -36.67% | 5M | -10.24% |
| New Positions | 26 | New | 2M | New |
| Sold Out Positions | 10 | Sold Out | 1M | Sold Out |
| Total Postitions | 140 | +16.67% | 51M | -0.64% |
| Blackrock, Inc. | $14,330.00 | 8.65% | 10.46M | -279,724 | -2.6% | 2025-09-30 |
| Vanguard Group Inc | $14,140.00 | 8.53% | 10.32M | -249,408 | -2.36% | 2025-09-30 |
| Tang Capital Management Llc | $6,983.00 | 4.21% | 5.1M | 0 | 0% | 2025-09-30 |
| Kohlberg Kravis Roberts & Co. L.P. | $4,159.00 | 2.51% | 3.04M | 0 | 0% | 2025-09-30 |
| Geode Capital Management, Llc | $3,755.00 | 2.27% | 2.74M | +64,750 | +2.42% | 2025-09-30 |
| State Street Corp | $3,046.00 | 1.84% | 2.22M | +4,843 | +0.22% | 2025-09-30 |
| Cm Management, Llc | $2,877.00 | 1.74% | 2.1M | -150,000 | -6.67% | 2025-09-30 |
| C Worldwide Group Holding A/S | $2,642.00 | 1.59% | 1.93M | 0 | 0% | 2025-09-30 |
| Panagora Asset Management Inc | $1,885.00 | 1.14% | 1.38M | +581,639 | +73.22% | 2025-09-30 |
| Charles Schwab Investment Management Inc | $1,361.00 | 0.82% | 993,092 | +11,720 | +1.19% | 2025-09-30 |